ICD-10 Coding for Metastatic Rectal Cancer(C22.0P, C78.7, C78.7B)
Learn about ICD-10 coding for metastatic rectal cancer, including primary and metastatic site codes, documentation requirements, and common pitfalls.
Complete code families applicable to Metastatic Rectal Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C20 | Malignant neoplasm of rectum | Use when rectal cancer is confirmed as the primary site. |
|
| C78.7 | Secondary malignant neoplasm of liver and intrahepatic bile duct | Use when liver metastasis is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMetastatic Rectal Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Metastatic Rectal Cancer.
Vague documentation of metastasis
Impact
Clinical: Impacts treatment decisions, Regulatory: Non-compliance with coding standards, Financial: Potential reimbursement issues
Mitigation
Use specific terms like 'liver metastasis', Include imaging and biopsy details
Incorrect sequencing of primary and metastatic codes
Impact
Reimbursement: Incorrect DRG assignment, Compliance: Potential audit flags, Data Quality: Inaccurate cancer registry data
Mitigation
Sequence metastatic code first if treatment is for metastasis.
Incorrect code sequencing
Impact
Metastatic codes not sequenced correctly based on treatment.
Mitigation
Review coding guidelines for sequencing rules.
Frequently Asked Questions
Primary Code
Malignant neoplasm of rectumC20Secondary malignant neoplasm of liver and intrahepatic bile duc